Redefining first-line standards: The role of next-generation HER2-Targeted therapies in HER2-positive metastatic breast cancer
- DOI
- 10.1016/j.bbcan.2026.189649
- Published
- 2026-09
- Container
- Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.bbcan.2026.189649,
title = {Redefining first-line standards: The role of next-generation HER2-Targeted therapies in HER2-positive metastatic breast cancer},
author = {Lanxin Zhang and Huazhang Li and Siwen Sun and Ning Li and Shanshan Zhao and Zuowei Zhao and Man Li},
year = {2026},
journal = {Biochimica et Biophysica Acta (BBA) - Reviews on Cancer},
doi = {10.1016/j.bbcan.2026.189649},
url = {https://doi.org/10.1016/j.bbcan.2026.189649}
}RIS
TY - JOUR TI - Redefining first-line standards: The role of next-generation HER2-Targeted therapies in HER2-positive metastatic breast cancer AU - Lanxin Zhang AU - Huazhang Li AU - Siwen Sun AU - Ning Li AU - Shanshan Zhao AU - Zuowei Zhao AU - Man Li PY - 2026 JO - Biochimica et Biophysica Acta (BBA) - Reviews on Cancer DO - 10.1016/j.bbcan.2026.189649 UR - https://doi.org/10.1016/j.bbcan.2026.189649 ER -
APA
Zhang, L., Li, H., Sun, S., Li, N., Zhao, S., Zhao, Z., & Li, M. (2026). Redefining first-line standards: The role of next-generation HER2-Targeted therapies in HER2-positive metastatic breast cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. https://doi.org/10.1016/j.bbcan.2026.189649
Source records
- crossref · retrieved 2026-09-26T15:53:38.286Z